Originally developed to reduce visceral fat in HIV-associated lipodystrophy, Tesamorelin has since gained popularity in the performance and anti-aging world for its potent effects on GH release, IGF-1 elevation, and tissue repair
1 Its incidence has steadily increased across all age groups over the past few years, contributing significantly to the global healthcare burden
BPC-157 doesn't interfere with GLP-1 receptor binding, doesn't alter insulin signaling, and doesn't affect the appetite-suppression pathways that GLP-1 medications target
Ensure you are getting adequate protein throughout the day
A deep level of lasting protection can be achieved with Candida sublingual drops
Rationale: Ipamorelin provides systemic GH elevation BPC-157 offers targeted tissue repair Combination accelerates injury healing Synergistic effects on recovery Protocol: Ipamorelin: 200-300 mcg at bedtime BPC-157: 250-500 mcg daily (can inject near injury site) See our BPC-157 dosing guide for detailed protocols